Name | 5,6-bis(4-methoxyphenyl)-3-methyl-1,2,4-triazine |
---|---|
Synonyms |
ANITRAZAFEN
Anitrazafene Anitrazafenum Anitrazafeno |
Description | Anitrazafen is a topically effective antiinflammatory agent. |
---|---|
Related Catalog | |
In Vivo | Anitrazafen is a topically effective antiinflammatory agent. The disposition of 14C in normal and in bile-duct cannulated rats after oral administration of a single dose of 25 mg/kg of [3-14C]Anitrazafen shows the drug to be well absorbed from the gastro-intestinal tract and biliary excretion to be the major route of elimination of drug and/or metabolites. Plasma concentrations of total 14C after subcutaneous administration of [3-14C]Anitrazafen in corn oil solution are about one half those found after oral administration[1]. |
Animal Admin | Male albino rats (200 to 250 g) are fasted for 24 h before experiment. [3-14C]Anitrazafen (25 mg/kg) is administered orally to twelve rats. At specific times after dosing, three animals are killed by decapitation and samples of blood and appropriate tissues are removed. Duplicate weighed samples of blood and each tissue are removed for 14C assay[1]. |
References |
Density | 1.164g/cm3 |
---|---|
Boiling Point | 482.8ºC at 760 mmHg |
Molecular Formula | C18H17N3O2 |
Molecular Weight | 307.34600 |
Flash Point | 172.1ºC |
Exact Mass | 307.13200 |
PSA | 57.13000 |
LogP | 3.53120 |
Index of Refraction | 1.58 |
Storage condition | 2-8℃ |
HS Code | 2933699090 |
---|
~% 63119-27-7 |
Literature: Eli Lilly and Company Patent: US4021553 A1, 1977 ; |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2933699090 |
---|---|
Summary | 2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0% |